000169379 001__ 169379
000169379 005__ 20240826165949.0
000169379 0247_ $$2doi$$a10.1186/s13195-022-01118-0
000169379 0247_ $$2pmid$$apmid:36631909
000169379 0247_ $$2pmc$$apmc:PMC9835320
000169379 0247_ $$2altmetric$$aaltmetric:141142629
000169379 037__ $$aDZNE-2023-00143
000169379 041__ $$aEnglish
000169379 082__ $$a610
000169379 1001_ $$0P:(DE-2719)2810593$$aBrosseron, Frederic$$b0$$eFirst author
000169379 245__ $$aSerum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.
000169379 260__ $$aLondon$$bBioMed Central$$c2023
000169379 3367_ $$2DRIVER$$aarticle
000169379 3367_ $$2DataCite$$aOutput Types/Journal article
000169379 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1709647383_29109
000169379 3367_ $$2BibTeX$$aARTICLE
000169379 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000169379 3367_ $$00$$2EndNote$$aJournal Article
000169379 520__ $$aNeuroinflammation constitutes a pathological hallmark of Alzheimer's disease (AD). Still, it remains unresolved if peripheral inflammatory markers can be utilized for research purposes similar to blood-based beta-amyloid and neurodegeneration measures. We investigated experimental inflammation markers in serum and analyzed interrelations towards AD pathology features in a cohort with a focus on at-risk stages of AD.Data of 74 healthy controls (HC), 99 subjective cognitive decline (SCD), 75 mild cognitive impairment (MCI), 23 AD relatives, and 38 AD subjects were obtained from the DELCODE cohort. A panel of 20 serum biomarkers was determined using immunoassays. Analyses were adjusted for age, sex, APOE status, and body mass index and included correlations between serum and CSF marker levels and AD biomarker levels. Group-wise comparisons were based on screening diagnosis and routine AD biomarker-based schematics. Structural imaging data were combined into composite scores representing Braak stage regions and related to serum biomarker levels. The Preclinical Alzheimer's Cognitive Composite (PACC5) score was used to test for associations between the biomarkers and cognitive performance.Each experimental marker displayed an individual profile of interrelations to AD biomarkers, imaging, or cognition features. Serum-soluble AXL (sAXL), IL-6, and YKL-40 showed the most striking associations. Soluble AXL was significantly elevated in AD subjects with pathological CSF beta-amyloid/tau profile and negatively related to structural imaging and cognitive function. Serum IL-6 was negatively correlated to structural measures of Braak regions, without associations to corresponding IL-6 CSF levels or other AD features. Serum YKL-40 correlated most consistently to CSF AD biomarker profiles and showed the strongest negative relations to structure, but none to cognitive outcomes.Serum sAXL, IL-6, and YKL-40 relate to different AD features, including the degree of neuropathology and cognitive functioning. This may suggest that peripheral blood signatures correspond to specific stages of the disease. As serum markers did not reflect the corresponding CSF protein levels, our data highlight the need to interpret serum inflammatory markers depending on the respective protein's specific biology and cellular origin. These marker-specific differences will have to be considered to further define and interpret blood-based inflammatory profiles for AD research.
000169379 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000169379 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x1
000169379 536__ $$0G:(DE-HGF)POF4-351$$a351 - Brain Function (POF4-351)$$cPOF4-351$$fPOF IV$$x2
000169379 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000169379 650_7 $$2Other$$aAlzheimer’s disease
000169379 650_7 $$2Other$$aAlzheimer’s disease
000169379 650_7 $$2Other$$aBiomarker
000169379 650_7 $$2Other$$aBlood-based
000169379 650_7 $$2Other$$aCognition
000169379 650_7 $$2Other$$aInflammation
000169379 650_7 $$2Other$$aStructural MRI
000169379 650_7 $$2NLM Chemicals$$aInterleukin-6
000169379 650_7 $$2NLM Chemicals$$aChitinase-3-Like Protein 1
000169379 650_7 $$2NLM Chemicals$$aAmyloid beta-Peptides
000169379 650_7 $$2NLM Chemicals$$aBiomarkers
000169379 650_7 $$2NLM Chemicals$$atau Proteins
000169379 650_7 $$2NLM Chemicals$$aAXL protein, human
000169379 650_2 $$2MeSH$$aAlzheimer Disease: blood
000169379 650_2 $$2MeSH$$aHumans
000169379 650_2 $$2MeSH$$aAlzheimer Disease: pathology
000169379 650_2 $$2MeSH$$aInterleukin-6
000169379 650_2 $$2MeSH$$aChitinase-3-Like Protein 1
000169379 650_2 $$2MeSH$$aAmyloid beta-Peptides
000169379 650_2 $$2MeSH$$aBrain: pathology
000169379 650_2 $$2MeSH$$aCognitive Dysfunction: diagnosis
000169379 650_2 $$2MeSH$$aBiomarkers
000169379 650_2 $$2MeSH$$atau Proteins
000169379 650_2 $$2MeSH$$aAmyloid beta-Peptides: cerebrospinal fluid
000169379 650_2 $$2MeSH$$aBiomarkers: blood
000169379 650_2 $$2MeSH$$aChitinase-3-Like Protein 1: blood
000169379 650_2 $$2MeSH$$aCognitive Dysfunction: blood
000169379 650_2 $$2MeSH$$aInterleukin-6: blood
000169379 650_2 $$2MeSH$$atau Proteins: cerebrospinal fluid
000169379 693__ $$0EXP:(DE-2719)DELCODE-20140101$$5EXP:(DE-2719)DELCODE-20140101$$eLongitudinal Cognitive Impairment and Dementia Study$$x0
000169379 7001_ $$0P:(DE-2719)2811815$$aMaass, Anne$$b1
000169379 7001_ $$0P:(DE-2719)2812139$$aKleineidam, Luca$$b2
000169379 7001_ $$0P:(DE-2719)9002244$$aRavichandran, Kishore Aravind$$b3
000169379 7001_ $$aKolbe, Carl-Christian$$b4
000169379 7001_ $$0P:(DE-2719)2810544$$aWolfsgruber, Steffen$$b5
000169379 7001_ $$0P:(DE-2719)2810567$$aSantarelli, Francesco$$b6
000169379 7001_ $$0P:(DE-2719)2811581$$aHäsler, Lisa M$$b7
000169379 7001_ $$0P:(DE-2719)2811671$$aMcManus, Róisín$$b8
000169379 7001_ $$0P:(DE-2719)2812463$$aIsing, Christina$$b9
000169379 7001_ $$0P:(DE-2719)2810395$$aRöske, Sandra$$b10
000169379 7001_ $$0P:(DE-2719)2811024$$aPeters, Oliver$$b11
000169379 7001_ $$0P:(DE-2719)9002259$$aCosma, Nicoleta-Carmen$$b12
000169379 7001_ $$0P:(DE-2719)9002878$$aSchneider, Luisa-Sophie$$b13$$udzne
000169379 7001_ $$aWang, Xiao$$b14
000169379 7001_ $$0P:(DE-2719)2811122$$aPriller, Josef$$b15
000169379 7001_ $$0P:(DE-2719)2812446$$aSpruth, Eike J$$b16
000169379 7001_ $$0P:(DE-2719)2811720$$aAltenstein, Slawek$$b17
000169379 7001_ $$0P:(DE-2719)2812035$$aSchneider, Anja$$b18
000169379 7001_ $$0P:(DE-2719)2811326$$aFliessbach, Klaus$$b19
000169379 7001_ $$0P:(DE-2719)2811317$$aWiltfang, Jens$$b20
000169379 7001_ $$0P:(DE-2719)2814326$$aSchott, Björn H$$b21
000169379 7001_ $$0P:(DE-2719)2811351$$aBuerger, Katharina$$b22
000169379 7001_ $$0P:(DE-2719)9002557$$aJanowitz, Daniel$$b23
000169379 7001_ $$0P:(DE-2719)2000030$$aDichgans, Martin$$b24
000169379 7001_ $$0P:(DE-2719)2812234$$aPerneczky, Robert$$b25
000169379 7001_ $$0P:(DE-2719)9001808$$aRauchmann, Boris-Stephan$$b26
000169379 7001_ $$0P:(DE-2719)2000026$$aTeipel, Stefan$$b27
000169379 7001_ $$0P:(DE-2719)2810394$$aKilimann, Ingo$$b28
000169379 7001_ $$0P:(DE-2719)2812583$$aGörß, Doreen$$b29
000169379 7001_ $$0P:(DE-2719)2000055$$aLaske, Christoph$$b30
000169379 7001_ $$0P:(DE-2719)9001516$$aMunk, Matthias H$$b31
000169379 7001_ $$0P:(DE-2719)2000005$$aDüzel, Emrah$$b32
000169379 7001_ $$0P:(DE-2719)2812398$$aYakupov, Renat$$b33
000169379 7001_ $$0P:(DE-2719)2811611$$aDobisch, Laura$$b34
000169379 7001_ $$0P:(DE-2719)9000443$$aMetzger, Coraline D$$b35
000169379 7001_ $$0P:(DE-2719)2811614$$aGlanz, Wenzel$$b36
000169379 7001_ $$0P:(DE-2719)9000543$$aEwers, Michael$$b37
000169379 7001_ $$aDechent, Peter$$b38
000169379 7001_ $$aHaynes, John Dylan$$b39
000169379 7001_ $$aScheffler, Klaus$$b40
000169379 7001_ $$0P:(DE-2719)2812341$$aRoy, Nina$$b41
000169379 7001_ $$aRostamzadeh, Ayda$$b42
000169379 7001_ $$0P:(DE-2719)2811324$$aSpottke, Annika$$b43
000169379 7001_ $$0P:(DE-2719)2812825$$aRamirez, Alfredo$$b44
000169379 7001_ $$0P:(DE-2719)9000375$$aMengel, David$$b45
000169379 7001_ $$0P:(DE-2719)2811275$$aSynofzik, Matthis$$b46
000169379 7001_ $$0P:(DE-2719)2000010$$aJucker, Mathias$$b47
000169379 7001_ $$0P:(DE-2719)2000062$$aLatz, Eicke$$b48
000169379 7001_ $$0P:(DE-2719)2000032$$aJessen, Frank$$b49
000169379 7001_ $$0P:(DE-2719)2000057$$aWagner, Michael$$b50
000169379 7001_ $$0P:(DE-2719)2000008$$aHeneka, Michael T$$b51$$eLast author
000169379 7001_ $$agroup, DELCODE study$$b52$$eCollaboration Author
000169379 773__ $$0PERI:(DE-600)2506521-X$$a10.1186/s13195-022-01118-0$$gVol. 15, no. 1, p. 13$$n1$$p13$$tAlzheimer's research & therapy$$v15$$x1758-9193$$y2023
000169379 8564_ $$uhttps://pub.dzne.de/record/169379/files/DZNE-2023-00143%20SUP.doc
000169379 8564_ $$uhttps://pub.dzne.de/record/169379/files/DZNE-2023-00143%20SUP.docx
000169379 8564_ $$uhttps://pub.dzne.de/record/169379/files/DZNE-2023-00143%20SUP.odt
000169379 8564_ $$uhttps://pub.dzne.de/record/169379/files/DZNE-2023-00143%20SUP.pdf
000169379 8564_ $$uhttps://pub.dzne.de/record/169379/files/DZNE-2023-00143.pdf$$yOpenAccess
000169379 8564_ $$uhttps://pub.dzne.de/record/169379/files/DZNE-2023-00143.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000169379 909CO $$ooai:pub.dzne.de:169379$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810593$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811815$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812139$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002244$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810544$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810567$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811581$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811671$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b8$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812463$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000169379 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2810395$$aExternal Institute$$b10$$kExtern
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811024$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b11$$kDZNE
000169379 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9002259$$aExternal Institute$$b12$$kExtern
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002878$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b13$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811122$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b15$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812446$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b16$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811720$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b17$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812035$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b18$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811326$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b19$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811317$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b20$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2814326$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b21$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811351$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b22$$kDZNE
000169379 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9002557$$aExternal Institute$$b23$$kExtern
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000030$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b24$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812234$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b25$$kDZNE
000169379 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9001808$$aExternal Institute$$b26$$kExtern
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000026$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b27$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810394$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b28$$kDZNE
000169379 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2812583$$aExternal Institute$$b29$$kExtern
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000055$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b30$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001516$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b31$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000005$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b32$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812398$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b33$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811611$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b34$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000443$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b35$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811614$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b36$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000543$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b37$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812341$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b41$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811324$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b43$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812825$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b44$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000375$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b45$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811275$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b46$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000010$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b47$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000062$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b48$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000032$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b49$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000057$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b50$$kDZNE
000169379 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000008$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b51$$kDZNE
000169379 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000169379 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x1
000169379 9131_ $$0G:(DE-HGF)POF4-351$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vBrain Function$$x2
000169379 9141_ $$y2023
000169379 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-08
000169379 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000169379 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-08
000169379 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-08
000169379 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000169379 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-08
000169379 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bALZHEIMERS RES THER : 2022$$d2023-08-19
000169379 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-19
000169379 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-19
000169379 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-19
000169379 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T15:09:21Z
000169379 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T15:09:21Z
000169379 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2023-04-12T15:09:21Z
000169379 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-19
000169379 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-19
000169379 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-19
000169379 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-19
000169379 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-19
000169379 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bALZHEIMERS RES THER : 2022$$d2023-08-19
000169379 9201_ $$0I:(DE-2719)1011301$$kBiomarker$$lInterventional Trials and Biomarkers in Neurodegenerative Diseases$$x0
000169379 9201_ $$0I:(DE-2719)1311001$$kAG Maaß$$lMultimodal Neuroimaging$$x1
000169379 9201_ $$0I:(DE-2719)1011201$$kAG Wagner$$lNeuropsychology$$x2
000169379 9201_ $$0I:(DE-2719)1011303$$kAG Heneka ; AG Heneka$$lNeuroinflammation, Biomarker$$x3
000169379 9201_ $$0I:(DE-2719)1210001$$kAG Jucker$$lCell Biology of Neurological Diseases$$x4
000169379 9201_ $$0I:(DE-2719)1810002$$kAG Dirnagl$$lVascular Pathology$$x5
000169379 9201_ $$0I:(DE-2719)5000007$$kAG Priller$$lTranslational Neuropsychiatry$$x6
000169379 9201_ $$0I:(DE-2719)5000006$$kAG Düzel$$lClinical Neurophysiology and Memory$$x7
000169379 9201_ $$0I:(DE-2719)1811005$$kAG Endres$$lInterdisciplinary Dementia Research$$x8
000169379 9201_ $$0I:(DE-2719)1011305$$kAG Schneider$$lTranslational Dementia Research (Bonn)$$x9
000169379 9201_ $$0I:(DE-2719)1011101$$kPatient Studies Bonn$$lPatient Studies Bonn$$x10
000169379 9201_ $$0I:(DE-2719)1410002$$kAG Fischer$$lEpigenetics and Systems Medicine in Neurodegenerative Diseases$$x11
000169379 9201_ $$0I:(DE-2719)1410006$$kAG Wiltfang$$lMolecular biomarkers for predictive diagnostics of neurodegenerative diseases$$x12
000169379 9201_ $$0I:(DE-2719)5000022$$kAG Dichgans$$lVascular Cognitive Impairment & Post-Stroke Dementia$$x13
000169379 9201_ $$0I:(DE-2719)1510100$$kAG Teipel$$lClinical Dementia Research (Rostock /Greifswald)$$x14
000169379 9201_ $$0I:(DE-2719)1210000$$kAG Gasser$$lParkinson Genetics$$x15
000169379 9201_ $$0I:(DE-2719)1340007$$kCore Technical Staff$$lCore KAP (Kooperationseinheit Angewandte Präventionsforschung)$$x16
000169379 9201_ $$0I:(DE-2719)1110008$$kAG Simons$$lMolecular Neurobiology$$x17
000169379 9201_ $$0I:(DE-2719)1011401$$kClinical Research Platform (CRP)$$lClinical Research Platform (CRP)$$x18
000169379 9201_ $$0I:(DE-2719)1013024$$kAG Latz ; AG Latz$$lInnate Immunity in Neurodegeneration$$x19
000169379 9201_ $$0I:(DE-2719)1011102$$kAG Jessen$$lClinical Alzheimer’s Disease Research$$x20
000169379 9201_ $$0I:(DE-2719)5000034$$kDelcode$$lDelcode$$x21
000169379 980__ $$ajournal
000169379 980__ $$aVDB
000169379 980__ $$aI:(DE-2719)1011301
000169379 980__ $$aI:(DE-2719)1311001
000169379 980__ $$aI:(DE-2719)1011201
000169379 980__ $$aI:(DE-2719)1011303
000169379 980__ $$aI:(DE-2719)1210001
000169379 980__ $$aI:(DE-2719)1810002
000169379 980__ $$aI:(DE-2719)5000007
000169379 980__ $$aI:(DE-2719)5000006
000169379 980__ $$aI:(DE-2719)1811005
000169379 980__ $$aI:(DE-2719)1011305
000169379 980__ $$aI:(DE-2719)1011101
000169379 980__ $$aI:(DE-2719)1410002
000169379 980__ $$aI:(DE-2719)1410006
000169379 980__ $$aI:(DE-2719)5000022
000169379 980__ $$aI:(DE-2719)1510100
000169379 980__ $$aI:(DE-2719)1210000
000169379 980__ $$aI:(DE-2719)1340007
000169379 980__ $$aI:(DE-2719)1110008
000169379 980__ $$aI:(DE-2719)1011401
000169379 980__ $$aI:(DE-2719)1013024
000169379 980__ $$aI:(DE-2719)1011102
000169379 980__ $$aI:(DE-2719)5000034
000169379 980__ $$aUNRESTRICTED
000169379 9801_ $$aFullTexts